Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Sep 8;289(6445):573–575. doi: 10.1136/bmj.289.6445.573

Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.

M Melbye, R J Biggar, P Ebbesen, M G Sarngadharan, S H Weiss, R C Gallo, W A Blattner
PMCID: PMC1442841  PMID: 6087972

Abstract

Sera taken from 250 Danish homosexual men in December 1981 as part of a prospective study of the acquired immunodeficiency syndrome (AIDS) were examined for the presence of HTLV-III antibody with an enzyme-linked immunosorbent assay. Antibody was present in 22 (8.8%) of the men. Seropositivity was most strongly associated with sexual exposure to men in the United States (relative risk 3.5; p less than 0.007). Increased frequency of anal receptive intercourse was also independently associated with seropositivity (p less than 0.05), but age, years of homosexual experience, number of homosexual partners, and use of nitrite inhalant were not independent risk factors. The frequency of seroconversion from absence to presence of HTLV-III antibody appeared to be about 1% a month in this community during December 1981 to February 1983. Of the 22 men who were originally seropositive, two (9%) subsequently developed AIDS as defined by the Centre for Disease Control and two (9%) others the AIDS related complex. Blood was taken in addition from two of the men to develop AIDS earliest in Denmark (diagnosed 1981) at the same time as the initial survey in 1981; both were seropositive. The spread of HTLV-III from high to low risk areas and the subsequent appearance of illnesses related to AIDS in the seropositive group support the hypothesis that HTLV-III is causally related to the development of AIDS.

Full text

PDF
573

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
  2. Biggar R. J., Andersen H. K., Ebbesen P., Melbye M., Goedert J. J., Mann D. L., Strong D. M. Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br Med J (Clin Res Ed) 1983 Jun 25;286(6383):2010–2012. doi: 10.1136/bmj.286.6383.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biggar R. J., Melbye M., Ebbesen P., Mann D. L., Goedert J. J., Weinstock R., Strong D. M., Blattner W. A. Low T-lymphocyte ratios in homosexual men. Epidemiologic evidence for a transmissible agent. JAMA. 1984 Mar 16;251(11):1441–1446. [PubMed] [Google Scholar]
  4. Brun-Vezinet F., Rouzioux C., Barre-Sinoussi F., Klatzmann D., Saimot A. G., Rozenbaum W., Christol D., Gluckmann J. C., Montagnier L., Chermann J. C. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet. 1984 Jun 9;1(8389):1253–1256. doi: 10.1016/s0140-6736(84)92444-9. [DOI] [PubMed] [Google Scholar]
  5. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  6. Jaffe H. W., Choi K., Thomas P. A., Haverkos H. W., Auerbach D. M., Guinan M. E., Rogers M. F., Spira T. J., Darrow W. W., Kramer M. A. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med. 1983 Aug;99(2):145–151. doi: 10.7326/0003-4819-99-2-145. [DOI] [PubMed] [Google Scholar]
  7. Marmor M., Friedman-Kien A. E., Laubenstein L., Byrum R. D., William D. C., D'onofrio S., Dubin N. Risk factors for Kaposi's sarcoma in homosexual men. Lancet. 1982 May 15;1(8281):1083–1087. doi: 10.1016/s0140-6736(82)92275-9. [DOI] [PubMed] [Google Scholar]
  8. Melbye M., Biggar R. J., Chermann J. C., Montagnier L., Stenbjerg S., Ebbesen P. High prevalence of lymphadenopathy virus (LAV) in European haemophiliacs. Lancet. 1984 Jul 7;2(8393):40–41. doi: 10.1016/s0140-6736(84)92023-3. [DOI] [PubMed] [Google Scholar]
  9. Melbye M., Biggar R. J., Ebbesen P., Andersen H. K., Vestergaard B. F. Lifestyle and antiviral antibody studies among homosexual men in Denmark. Acta Pathol Microbiol Immunol Scand B. 1983 Oct;91(5):357–364. doi: 10.1111/j.1699-0463.1983.tb00060.x. [DOI] [PubMed] [Google Scholar]
  10. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  11. Sarngadharan M. G., Popovic M., Bruch L., Schüpbach J., Gallo R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. doi: 10.1126/science.6324345. [DOI] [PubMed] [Google Scholar]
  12. Schüpbach J., Popovic M., Gilden R. V., Gonda M. A., Sarngadharan M. G., Gallo R. C. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science. 1984 May 4;224(4648):503–505. doi: 10.1126/science.6200937. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES